NurExone Biologic Financial Overview
NurExone Biologic's market cap is currently C$48.98M. The company's EPS TTM is C$-0.0273539436; its P/E ratio is -5.42; NurExone Biologic is scheduled to report earnings on November 26, 2025, and the estimated EPS forecast is C$0.03. See an overview of income statement, balance sheet, and cash flow financials.
